Mixed Connective Tissue Disease with Severe Pulmonary Hypertension and Extensive Subcutaneous Calcification

Internal Medicine

Volumn 37, Issue 4, 1998, Pages 421-425

  Itoh, Osamu ^a   Nishimaki, Tomoe ^a   Itoh, Masayuki ^a   Ohira, Hiromasa ^a   Irisawa, Atsushi ^a   Kaise, Syunji ^a   Kasukawa, Reiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcinosis; Mixed connective tissue disease (MCTD); Pericarditis; Pulmonary hypertension (PH)

Indexed keywords

ADULT; ARTICLE; CALCINOSIS; CASE REPORT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATALITY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; PATHOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; RADIOGRAPHY; SKIN DISEASE;

ADULT; CALCINOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MIXED CONNECTIVE TISSUE DISEASE; PULMONARY ARTERY; SKIN DISEASES;

EID: 0032041847     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.421     Document Type: Article

References (26)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease, an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148, 1972.
2. Hosoda Y. Pathohistologic analysis of pulmonary lesions in patients with collagen diseases complicated by pulmonary hypertension. Ryumachi 24: 431, 1984 (Abstract in English).
3. Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T. Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 9: 56, 1990.
4. Sharp GC, Irvin WS, May CM, et al. Association of antibodies to ribonucleoprotein and SM antigens with mixed connective tissue disease, systemic lupus erythematosus (SLE) and other rheumatic diseases. N Engl J Med 295: 1149, 1976.
5. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. in: Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, Kasukawa R. Sharp GC, Eds. Excerpta Medica, Amsterdam, 1987, ICS No. 719, p. 33.
6. Hosoda Y, Suzuki Y, Takano M, Tojo T, Homma M. Mixed connective tissue disease with pulmonary hypertension: A clinical and pathological study. J Rheumatol 14: 826, 1987.
7. Yoshio T, Masuyama J, Sumiya M, Minota S, Kano S. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 21: 2058, 1994.
8. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732, 1993.
9. Vancheeswaran R, Magoulas T, Efrat G, et al. Circulating endothelin-l levels in systemic sclerosis subsets - a marker of fibrosis or vascular dysfunction? J Rheumatol 21: 1838, 1994.
10. Nishimaki T, Yokohari R, Aotsuka S, et al. Prospective questionnaire survey on pulmonary hypertension in patients with mixed connective tissue disease. Annual report of the research committee for mixed connective tissue disease of the Ministry of Health and Welfare of Japan. 24, 1986.
11. Johansson E, Kanerva L, Niemi KM, Valimaki MM. Diffuse soft tissue calcifications (calcinosis cutis) in a patient with discoid lupus erythematosus. Clin Exp Dermatol 13: 193, 1988.
12. Muller SA, Brunsting LA, Winkelmann RK. Calcinosis cutis: its relationship to scleroderma. Arch Dermatol 80: 15, 1959.
13. Carr RO, Heisel EB, Stevenson TD. CREST syndrome. A benign variant of scleroderma. Arch Dermatol 92: 519, 1965.
14. Muller SA, Winkelmenn RK, Brunsting LA. Calcinosis in dermatomyositis. Arch Dermatol 79: 669, 1959.
15. Kabir DI, Malkinson FD. Lupus erythematosus and calcinosis. Arch Dermatol 100: 17, 1969.
16. Talbott JH, Koepf GF, Culver GC, et al. Dermatomyositis disseminated calcinosis and metaplastic ossification. Clinical studies over a period of seven years in a female with rheumatoid arthritis. Arthritis Rheum 2: 499, 1959.
17. Weinberg A, Kaplan JG, Myers AP. Extensive soft tissue calcification (calcinosis universalis) in systemic lupus erythematosus. Ann Rheum Dis 38: 384, 1979.
18. Hudson PM, Jones PE, Robinson TW, Dent CE. Extensive calcinosis with minimal scleroderma: Treatment of ectopic calcifications with aluminium hydroxide. Proc R Soc Med 67: 1166, 1974.
19. Baurle G, Hornstein OP. Generalized cutaneous calcinosis and mixed connective tissue disease. Dermatologica 158: 257, 1979.
20. Glimcher MJ, Krane SM. Studies on the interactions of collagen and phosphate. in: Radioisotope and Bone, A Symposium, Mclean FC, Ed. FA Davis Co Publisher, Philadelphia, 1962, p. 393.
21. Florey HW. General Pathology. 4th ed. WB Saunders Co, Philadelphia, 1970, p. 435.
22. Powell RJ. Systemic lupus erythematosus with widespread subcutaneous fat calcification. Proc R Soc Med 67: 215, 1974.
23. Quismorio FP, Dubois EL, Chandor SB. Soft tissue calcification in systemic lupus erythematosus. Arch Dermatol 111: 352, 1975.
24. Simons-Ling N, Schachner L, Penneys N, Gorman H, Zillereulo G, Strauss J. Childhood systemic lupus erythematosus: association with pancreatitis, subcutaneous fat necrosis, and calcinosiscutis. Arch Dermatol 119: 491, 1983.
25. Wang WJ, Lo WL, Wong CK. Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminium hydroxide therapy. Arch Dermatol 124: 1721, 1988 (letter).
26. Cram RL, Barmada R, Geho WB, Ray RD. Diphosphonate treatment of calcinosis universalis. N Engl J Med 285: 1012, 1971.